Cited by 181Mechanisms of cancer metastasisCell Adhesion Molecules ResearchCancer Cells and Metastasis

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

MYC suppresses cancer metastasis by direct transcriptional silencing of αv and β3 integrin subunits

Open access

Liu, Hong, Radisky, Derek C., Yang, Dun, Xu, Ren, Radisky, Evette S., Bissell, Mina J., Bishop, J. Michael·2012·Nature Cell Biology

DOI 10.1038/ncb2491PMC PMC3366024

Open this paper in CoChat — free account

Abstract

Overexpression of MYC transforms cells in culture, elicits malignant tumours in experimental animals and is found in many human tumours. We now report the paradoxical finding that this powerful oncogene can also act as a suppressor of cell motility, invasiveness and metastasis. Overexpression of MYC stimulated proliferation of breast cancer cells both in culture and in vivo as expected, but inhibited motility and invasiveness in culture, and lung and liver metastases in xenografted tumours. We show further that MYC represses transcription of both subunits of αvβ3 integrin, and that exogenous expression of β3 integrin in human breast cancer cells that do not express this integrin rescues invasiveness and migration when MYC is downregulated. These data uncover an unexpected function of MYC, provide an explanation for the hitherto puzzling literature on the relationship between MYC and metastasis, and reveal a variable that could influence the development of therapies that target MYC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/ncb2491

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cell Migration: Integrating Signals from Front to Back
Ridley, A. J., Schwartz, M. A., Burridge, K., Firtel, R., Ginsberg, M. H., Borisy, G. G., Parsons, J. T., & Horwitz, A. R. (2003) · Science · doi:10.1126/science.1092053 · Cited by 5,109
Tumour-cell invasion and migration: diversity and escape mechanisms
Friedl, P., & Wolf, K. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1075 · Cited by 3,350
The extracellular matrix: A dynamic niche in cancer progression
Lu, P., Weaver, V. M., & Werb, Z. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201102147 · Cited by 3,024
Role of integrins in cell invasion and migration
Hood, J. D., & Cheresh, D. A. (2002) · Nature reviews. Cancer · doi:10.1038/nrc727 · Cited by 1,798
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
Dang, C. V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.1 · Cited by 1,722
Reflecting on 25 years with MYC
Meyer, N., & Penn, L. Z. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2231 · Cited by 1,575
Integrin signalling during tumour progression
Guo, W., & Giancotti, F. G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1490 · Cited by 1,522
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
Ma, L., Young, J. J., Prabhala, H. K., Pan, E., Mestdagh, P., Muth, D., Teruya‐Feldstein, J., Reinhardt, F., Önder, T. T., Valastyan, S., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2024 · Cited by 1,358
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
Grandori, C., Cowley, S. M., James, L. P., & Eisenman, R. N. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.653 · Cited by 1,333
Systemic Spread Is an Early Step in Breast Cancer
Hüsemann, Y., Geigl, J. B., Schubert, F., Musiani, P., Meyer, M., Burghart, E., Forni, G., Eils, R., Fehm, T. N., Riethmüller, G., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.12.003 · Cited by 1,220

Flagged first, then by citations

Show all 51 references

Sorted by citations

The PI3K Pathway in Human Disease
Fruman, D. A., Chiu, H., Hopkins, B. D., Bagrodia, S., Cantley, L. C., & Abraham, R. T. (2017) · Cell · doi:10.1016/j.cell.2017.07.029 · Cited by 2,749
Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance
Cooper, J. M., & Giancotti, F. G. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.007 · Cited by 967
Early dissemination seeds metastasis in breast cancer
Hosseini, H., Obradović, M. M. S., Hoffmann, M., Harper, K. L., Sosa, M. S., Werner‐Klein, M., Nanduri, L. K., Werno, C., Ehrl, C., Maneck, M., et al. (2016) · Nature · doi:10.1038/nature20785 · Cited by 762
The integrin adhesome: from genes and proteins to human disease
Winograd-Katz, S. E., Fässler, R., Geiger, B., & Legate, K. R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3769 · Cited by 641
CCAT2 , a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancerPreprint
Ling, H. Y., Spizzo, R., Atlasi, Y., Nicoloso, M. S., Shimizu, M., Redis, R. S., Nishida, N., Gafà, R., Song, J. H., Guo, Z., et al. (2013) · Genome Research · doi:10.1101/gr.152942.112 · Cited by 605
Mitochondrial Dysfunction in Cancer
Boland, M. L., Chourasia, A. H., & Macleod, K. F. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00292 · Cited by 521
β1- and αv-class integrins cooperate to regulate myosin II during rigidity sensing of fibronectin-based microenvironments
Schiller, H. B., Hermann, M.-R., Polleux, J., Vignaud, T., Zanivan, S. R., Friedel, C. C., Sun, Z., Raducanu, A., Gottschalk, K., Théry, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2747 · Cited by 455
Cancer progression and the invisible phase of metastatic colonization
Klein, C. A. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-00300-6 · Cited by 387
Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma
Zhang, L., Yang, F., Yuan, J., Yuan, S., Zhou, W., Huo, X., Xu, D., Bi, H.-S., Wang, F., & Sun, S. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs381 · Cited by 334
Parkin targets HIF-1α for ubiquitination and degradation to inhibit breast tumor progression
Liu, J., Zhang, C., Zhao, Y., Yue, X., Wu, H., HUANG, S. H., Chen, J., Tomsky, K., Xie, H., Khella, C. A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01947-w · Cited by 213
Integrin Beta 3 Regulates Cellular Senescence by Activating the TGF-β Pathway
Rapisarda, V., Borghesan, M., Miguela, V., Encheva, V., Snijders, A. P., Lujambio, A., & O’Loghlen, A. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.012 · Cited by 190
Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer
Janghorban, M., Farrell, A. S., Allen-Petersen, B. L., Pelz, C., Daniel, C. J., Oddo, J., Langer, E. M., Christensen, D. J., & Sears, R. C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317630111 · Cited by 186
Integrins in cancer: Emerging mechanisms and therapeutic opportunities
Liu, F., Wu, Q., Dong, Z., & Liu, K. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108458 · Cited by 202
The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease
Seeger‐Nukpezah, T., Geynisman, D. M., Nikonova, A. S., Benzing, T. R., & Golemis, E. A. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.46 · Cited by 141
A MYC-Driven Change in Mitochondrial Dynamics Limits YAP/TAZ Function in Mammary Epithelial Cells and Breast Cancer
von Eyß, B., Jaenicke, L. A., Kortlever, R. M., Royla, N., Wiese, K. E., Letschert, S., McDuffus, L., Sauer, M., Rosenwald, A., Evan, G. I., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.10.013 · Cited by 142
c-MYC-regulated miR-23a/24-2/27a Cluster Promotes Mammary Carcinoma Cell Invasion and Hepatic Metastasis by Targeting Sprouty2
Li, X., Liu, X., Xu, W., Zhou, P., Gao, P., Jiang, S., Lobie, P. E., & Zhu, T. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.478560 · Cited by 140
Extracellular matrix dynamics in tumor immunoregulation: from tumor microenvironment to immunotherapy
Hu, Q., Zhu, Y., Mei, J., Liu, Y. L., & Zhou, G. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01717-y · Cited by 157
The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types
Fancello, L., Kampen, K. R., Hofman, I. J., Verbeeck, J., & Keersmaecker, K. D. (2017) · Oncotarget · doi:10.18632/oncotarget.14895 · Cited by 126
Tumor-Associated Macrophages Derived TGF-β‒Induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells through Smad2,3-4/Snail Signaling Pathway
Cai, J., Xia, L., Li, J., Ni, S., Song, H., & Wu, X. (2018) · Cancer Research and Treatment · doi:10.4143/crt.2017.613 · Cited by 119
The Role of MIZ-1 in MYC-Dependent TumorigenesisPreprint
Wiese, K. E., Walz, S., von Eyß, B., Wolf, E., Athineos, D., Sansom, O. J., & Eilers, M. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014290 · Cited by 114
MicroRNAs as regulators and mediators of c-MYC function
Jackstadt, R., & Hermeking, H. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.04.003 · Cited by 117
FBXO22 Possesses Both Protumorigenic and Antimetastatic Roles in Breast Cancer Progression
Sun, R., Xie, H.-Y., Qian, J.-X., Huang, Y.-N., Yang, F., Zhang, F.-L., Shao, Z., & Li, D. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3647 · Cited by 107
A Cancer Theory Kerfuffle Can Lead to New Lines of Research
Baker, S. G. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju405 · Cited by 107
Digging deeper through glucose metabolism and its regulators in cancer and metastasis
Ghanavat, M., Shahrouzian, M., Zayeri, Z. D., Banihashemi, S., Kazemi, S. M., & Saki, N. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118603 · Cited by 100
Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis
Ricciardiello, F., Votta, G., Palorini, R., Raccagni, I., Brunelli, L., Paiotta, A., Tinelli, F., D’Orazio, G., Valtorta, S., GIOIA, L. D., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0405-4 · Cited by 88
Metastasis suppressors: functional pathways
Khan, I., & Steeg, P. S. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.104 · Cited by 93
Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanoma
Werner‐Klein, M., Scheitler, S., Hoffmann, M., Hodak, I., Dietz, K., Lehnert, P., Naimer, V., Polzer, B. M., Treitschke, S., Werno, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02674-y · Cited by 91
Triple Negative Breast Cancer: A Multi-Omics Network Discovery Strategy for Candidate Targets and Driving Pathways
Karagoz, K., Sinha, R., & Arğa, K. Y. (2015) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2014.0135 · Cited by 86
Metabolic Profiling Reveals a Dependency of Human Metastatic Breast Cancer on Mitochondrial Serine and One-Carbon Unit Metabolism
Li, A. M., Ducker, G. S., Li, Y., Seoane, J. A., Xiao, Y., Melemenidis, S., Zhou, Y., Liu, L., Vanharanta, S., Graves, E. E., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0606 · Cited by 84
MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRγ*
Lü, M., Ding, K., Zhang, G., Yin, M., Yao, G., Tian, H., Lian, J., Liu, L., Liang, M., Zhu, T., et al. (2015) · Scientific Reports · doi:10.1038/srep08735 · Cited by 85
The MZF1/c-MYC axis mediates lung adenocarcinoma progression caused by wild-type lkb1 loss
Tsai, L.-H., Wu, J.-Y., Cheng, Y.-W., Chen, C.-Y., Sheu, G., Wu, T.-C., & Lee, H. (2014) · Oncogene · doi:10.1038/onc.2014.118 · Cited by 80
Eya3 partners with PP2A to induce c-Myc stabilization and tumor progression
Zhang, L., Zhou, H., Li, X., Vartuli, R. L., Rowse, M., Xing, Y., Rudra, P., Ghosh, D., Zhao, R., & Ford, H. L. (2018) · Nature Communications · doi:10.1038/s41467-018-03327-4 · Cited by 73
PTCSC3 Is Involved in Papillary Thyroid Carcinoma Development by ModulatingS100A4Gene Expression
Jendrzejewski, J., Thomas, A., Liyanarachchi, S., Eiterman, A., Tomšič, J., He, H., Radomska, H. S., Li, W., Nagy, R. S., Sworczak, K., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2247 · Cited by 73
c-MYC Drives Breast Cancer Metastasis to the Brain, but Promotes Synthetic Lethality with TRAIL
Lee, H. Y., Cha, J., Kim, S., Park, J., Song, K. H., Kim, P., & Kim, M. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0630 · Cited by 69
The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis
Aprelikova, O. N., Chen, K., Touny, L. H. E., Brignatz, C., Han, J. S., Qiu, T., Yang, H. H., Lee, M. P., Zhu, M., & Green, J. E. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0205-6 · Cited by 69
β1 and β3 integrins in breast, prostate and pancreatic cancer: A novel implication (Review)
Pan, B., Guo, J., Liao, Q., & Zhao, Y. (2018) · Oncology Letters · doi:10.3892/ol.2018.8076 · Cited by 69
Arsenic trioxide inhibits liver cancer stem cells and metastasis by targeting SRF/MCM7 complex
Wang, H., Zhang, B., Zhou, J., Wang, D., Xu, Y., Zeng, Q., Jia, Y., Xi, J., Nan, X., He, L., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1676-0 · Cited by 67
Molecular Pathways: Emerging Roles of Mammalian Sirtuin SIRT7 in Cancer
Paredes, S., Villanova, L., & Chua, K. F. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1547 · Cited by 65
Epigenetics and environment in breast cancer: New paradigms for anti-cancer therapies
Thakur, C., Qiu, Y., Fu, Y. S., Bi, Z., Zhang, W., Ji, H., & Chen, F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.971288 · Cited by 74
MicroRNA-33a Mediates the Regulation of High Mobility Group AT-Hook 2 Gene (HMGA2) by Thyroid Transcription Factor 1 (TTF-1/NKX2–1)
Rice, S. J., Lai, S., Wood, L. W., Helsley, K. R., Runkle, E. A., Winslow, M. M., & Mu, D. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.474643 · Cited by 61
Systematic analysis of metastasis-associated genes identifies miR-17-5p as a metastatic suppressor of basal-like breast cancer
Fan, M., Sethuraman, A., Brown, M., Sun, W., & Pfeffer, L. M. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3040-5 · Cited by 62
CBX8 Suppresses Tumor Metastasis via Repressing Snail in Esophageal Squamous Cell Carcinoma
Wang, G., Tang, J., Zhan, W., Zhang, R., Zhang, M., Liao, D., Wang, X., Wu, Y., & Kang, T. (2017) · Theranostics · doi:10.7150/thno.20717 · Cited by 60
Paradoxical role of CBX8 in proliferation and metastasis of colorectal cancer
Tang, J., Wang, G., Zhang, M., Li, F., Sang, Y., Wang, B., Hu, K., Wu, Y., Luo, R., Liao, D., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2502 · Cited by 59
Self-citation
Metastatic triple negative breast cancer adapts its metabolism to destination tissues while retaining key metabolic signatures
Roshanzamir, F., Robinson, J. L., Cook, D., Karimi‐Jafari, M. H., & Nielsen, J. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2205456119 · Cited by 60
p38 MAPK inhibits breast cancer metastasis through regulation of stromal expansion
Hong, B., Li, H., Zhang, M., Xu, J., Lu, Y., Zheng, Y., Qian, J., Chang, J. T., Yang, J., & Yi, Q. (2014) · International Journal of Cancer · doi:10.1002/ijc.28958 · Cited by 59
BRD4 Short Isoform Interacts with RRP1B, SIPA1 and Components of the LINC Complex at the Inner Face of the Nuclear Membrane
Alsarraj, J., Faraji, F., Geiger, T. R., Mattaini, K. R., Williams, M. F., Wu, J. J., Ha, N., Merlino, T., Walker, R. C., Bosley, A. D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080746 · Cited by 58
Interplay between NRF1, E2F4 and MYC transcription factors regulating common target genes contributes to cancer development and progression
Bhawe, K. M., & Roy, D. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0395-3 · Cited by 55
Myc coordinates transcription and translation to enhance transformation and suppress invasiveness
Elkon, R., Loayza‐Puch, F., Korkmaz, G., Lopes, R., Breugel, P. C. V., Bleijerveld, O. B., Altelaar, M. A. F., Wolf, E., Lorenzin, F., Eilers, M., et al. (2015) · EMBO Reports · doi:10.15252/embr.201540717 · Cited by 57
αvβ3 Integrin induces partial EMT independent of TGF-β signaling
Kariya, Y., Oyama, M., Suzuki, T., & Kariya, Y. (2021) · Communications Biology · doi:10.1038/s42003-021-02003-6 · Cited by 56
Extracellular matrix as a contextual determinant of transforming growth factor-β signaling in epithelial-mesenchymal transition and in cancer
Cichon, M. A., & Radisky, D. C. (2014) · Cell Adhesion & Migration · doi:10.4161/19336918.2014.972788 · Cited by 56
Self-citation
MicroRNA-92b represses invasion-metastasis cascade of esophageal squamous cell carcinoma
Ma, G., Jing, C., Lin, L., Huang, F., Ding, F., Wang, B., Lin, D., Luo, A., & Liu, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.7747 · Cited by 54
Systems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and “swarm intelligence”
Tarabichi, M., Antoniou, A., Saiselet, M., Pita, J. M. G., Andry, G., Dumont, J. E., Detours, V., & Maenhaut, C. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9431-y · Cited by 51
Occludin Is a Direct Target of Thyroid Transcription Factor-1 (TTF-1/NKX2–1)
Runkle, E. A., Rice, S. J., Qi, J., Masser, D. R., Antonetti, D. A., Winslow, M. M., & Mu, D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.367987 · Cited by 50
CREB1 contributes colorectal cancer cell plasticity by regulating lncRNA CCAT1 and NF-κB pathways
Li, B., Zheng, L., Ye, J., Zhang, C., Zhou, J. H. S., Huang, Q.-J., Guo, Y., Wang, L., Yu, P., Liu, S., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-022-2108-x · Cited by 52
The Kinase LMTK3 Promotes Invasion in Breast Cancer Through GRB2-Mediated Induction of Integrin β 1
Xu, Y., Zhang, H., Lit, L. C., Grothey, A., Athanasiadou, M., Kiritsi, M., Lombardo, Y., Frampton, A. E., Green, A. R., Ellis, I. O., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2005170 · Cited by 48
Myc suppresses tumor invasion and cell migration by inhibiting JNK signaling
Ma, X., Huang, J.-Y., Tian, Y., Chen, Y., Yang, Y., Zhang, X., Zhang, F., & Xue, L. (2017) · Oncogene · doi:10.1038/onc.2016.463 · Cited by 50
Adipose tissue dysfunction and its effects on tumor metabolism
Diedrich, J. D., Chkourko, H., & Podgorski, I. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0045 · Cited by 47
The Future of Polycystic Kidney Disease Research—As Seen By the 12 Kaplan Awardees
Antignac, C., Calvet, J. P., Germino, G. G., Grantham, J. J., Guay‐Woodford, L. M., Harris, P. C., Hildebrandt, F., Peters, D. J. M., Somlo, S., Torres, V. E., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014121192 · Cited by 45
Metallopanstimulin-1 regulates invasion and migration of gastric cancer cells partially through integrin β4
Yang, Z., Jiang, H., Qu, Y., Wei, M., Yan, M., Zhu, Z., Liu, B., Chen, G., Wu, Y., & Gu, Q. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt226 · Cited by 44
Lung-specific metastasis: the coevolution of tumor cells and lung microenvironment
Xiao, G., Wang, X., Xu, Z., Liu, Y., & Jing, J. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02318-6 · Cited by 44
Oncogenic Protein MTBP Interacts with MYC to Promote Tumorigenesis
Grieb, B. C., Gramling, M., Arrate, M. P., Chen, X., Beauparlant, S. L., Haines, D. S., Xiao, H., & Eischen, C. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2149 · Cited by 42
Molecular mediators of breast cancer metastasis
Yeeravalli, R., & Das, A. (2021) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2021.02.002 · Cited by 44
Avβ3 integrin: Pathogenetic role in osteotropic tumors
Stucci, L. S., Tucci, M., Passarelli, A. M., & Silvestris, F. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.05.018 · Cited by 40
Bone sialoprotein‐αvβ3 integrin axis promotes breast cancer metastasis to the bone
Wang, L., Song, L., Li, J., Wang, Y., Yang, C., Kou, X., Xiao, B., Zhang, W., Li, L., Liu, S., et al. (2019) · Cancer Science · doi:10.1111/cas.14172 · Cited by 40
Rho kinase inhibition drives megakaryocyte polyploidization and proplatelet formation through MYC and NFE 2 downregulation
Avanzi, M. P., Goldberg, F., Davila, J. G., Langhi, D. M., CHIATTONE, C. S., & Mitchell, W. B. (2014) · British Journal of Haematology · doi:10.1111/bjh.12709 · Cited by 39
Adaptive Fibrogenic Reprogramming of Osteosarcoma Stem Cells Promotes Metastatic Growth
Zhang, W., Zhao, J.-M., Lin, J., Hu, C.-Z., Zhang, J., YANG, W.-L., Zhang, J., Zhang, J., & Zhu, J. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.103 · Cited by 40
Integrins activate trimeric G proteins via the nonreceptor protein GIV/Girdin
Leyme, A., Marivin, A., Pérez, L., Nguyen, L. T., & Garcia‐Marcos, M. (2015) · The Journal of Cell Biology · doi:10.1083/jcb.201506041 · Cited by 37
Targeting MYC at the intersection between cancer metabolism and oncoimmunology
Venkatraman, S., Balasubramanian, B., Thuwajit, C., Meller, J., Tohtong, R., & Chutipongtanate, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1324045 · Cited by 40
Loss of mdig expression enhances DNA and histone methylation and metastasis of aggressive breast cancer
Thakur, C., Chen, B., Li, L., Zhang, Q., Yang, Z.-Q., & Chen, F. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0027-4 · Cited by 36
c-Kit Is Suppressed in Human Colon Cancer Tissue and Contributes to L1-Mediated Metastasis
Gavert, N. S., Shvab, A., Sheffer, M., Ben‐Shmuel, A., Haase, G., Bakos, E., Domany, E., & Ben‐Ze'ev, A. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0576 · Cited by 36
cAMP Elevation Down-Regulates β 3 Integrin and Focal Adhesion Kinase and Inhibits Leptin-Induced Migration of MDA-MB-231 Breast Cancer Cells
Spina, A., Maiolo, F. D., Esposito, A., Sapio, L., Chiosi, E., Sorvillo, L., & Naviglio, S. (2012) · BioResearch open access · doi:10.1089/biores.2012.0270 · Cited by 36
The Role of Noncoding RNAs in the Regulation of Anoikis and Anchorage-Independent Growth in Cancer
Lee, H. Y., Son, S. W., Moeng, S., Choi, S. Y., & Park, J. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020627 · Cited by 35
MTBP Is Overexpressed in Triple-Negative Breast Cancer and Contributes to Its Growth and Survival
Grieb, B. C., Chen, X., & Eischen, C. M. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0069 · Cited by 35
Site-specific amino acid substitution in dodecameric peptides determines the stability and unfolding ofc-MYCquadruplex promoting apoptosis in cancer cells
Sengupta, P., Banerjee, N., Roychowdhury, T., Dutta, A., Chattopadhyay, S., & Chatterjee, S. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky824 · Cited by 34
The Complexity of Thyroid Transcription Factor 1 with Both Pro- and Anti-oncogenic Activities
Mu, D. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.r113.491647 · Cited by 33
MYC Is an Early Response Regulator of Human Adipogenesis in Adipose Stem Cells
Deisenroth, C., Black, M. B., Pendse, S. N., Pluta, L., Witherspoon, S. M., McMullen, P. D., & Thomas, R. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114133 · Cited by 35
Wnt/β-Catenin Target Genes in Colon Cancer Metastasis: The Special Case of L1CAM
Cheriyamundath, S., & Ben‐Ze'ev, A. (2020) · Cancers · doi:10.3390/cancers12113444 · Cited by 33
Repression of SRF target genes is critical for Myc‐dependent apoptosis of epithelial cells
Wiese, K. E., Haikala, H. M., von Eyß, B., Wolf, E., Esnault, C., Rosenwald, A., Treisman, R., Klefström, J. T., & Eilers, M. (2015) · The EMBO Journal · doi:10.15252/embj.201490467 · Cited by 32
Oncogenic zinc finger protein ZNF322A promotes stem cell-like properties in lung cancer through transcriptional suppression of c-Myc expression
Jen, J., Liu, C., Chen, Y., Wu, L., Shieh, Y.-C., Lai, W., & Wang, Y. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0204-6 · Cited by 33
Truncated G-Quadruplex Isomers Cross-Talk with the Transcription Factors To Maintain Homeostatic Equilibria in c-MYC Transcription
Sengupta, P., Bhattacharya, A., Sa, G., Das, T., & Chatterjee, S. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00030 · Cited by 32
ERα is required for suppressing OCT4‐induced proliferation of breast cancer cells via DNMT1/ISL1/ERK axis
Jin, X., Li, Y., Guo, Y., Jia, Y., Qu, H., Lü, Y., Song, P., Zhang, X., Shao, Y., Qi, D., et al. (2019) · Cell Proliferation · doi:10.1111/cpr.12612 · Cited by 32
ESCO2 inhibits tumor metastasis via transcriptionally repressing MMP2 in colorectal cancer
Guo, X., Huang, B., Pan, Y., Su, S., & Li, Y. (2018) · Cancer Management and Research · doi:10.2147/cmar.s181265 · Cited by 31
FBXO28 suppresses liver cancer invasion and metastasis by promoting PKA-dependent SNAI2 degradation
Qiao, X., Lin, J., Shen, J., Yang, C., Zheng, L., Ren, H., Zhao, X., Yang, H., Li, P., & Wang, Z. (2023) · Oncogene · doi:10.1038/s41388-023-02809-0 · Cited by 31
NOP14 suppresses breast cancer progression by inhibiting NRIP1/Wnt/β-catenin pathway
Lei, J.-J., Peng, R., Kuang, B., Yuan, Z.-Y., Qin, T., Liu, W., Guo, Y., Han, H.-Q., Lian, Y., Deng, C.-C., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4573 · Cited by 31
Overexpression of Oct4 suppresses the metastatic potential of breast cancer cells via Rnd1 downregulation
Shen, L., Qin, K., Wang, D., Zhang, Y., Bai, N., Yang, S., Luo, Y., Xiang, R., & Tan, X. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.07.015 · Cited by 31
The expression of VE-cadherin in breast cancer cells modulates cell dynamics as a function of tumor differentiation and promotes tumor–endothelial cell interactions
Rezaei, M., Cao, J., Friedrich, K., Kemper, B., Brendel, O., Großer, M., Adrian, M., Baretton, G. B., Breier, G., & Schnittler, H. (2017) · Histochemistry and Cell Biology · doi:10.1007/s00418-017-1619-8 · Cited by 30
Low expression of miR-let-7a promotes cell growth and invasion through the regulation of c-Myc in oral squamous cell carcinoma
Luo, C., Zhang, J., Zhang, Y., Zhang, X., Chen, Y., & Fan, W. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1786633 · Cited by 30
MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and Seeding
Massó-Vallés, D., Beaulieu, M.-È., Jauset, T., Giuntini, F., Fluck, M. F. Z., Foradada, L., Martínez-Martín, S., Serrano, E., Martín-Fernández, G., Casacuberta‐Serra, S., et al. (2022) · Cancer Research Communications · doi:10.1158/2767-9764.crc-21-0103 · Cited by 31
BSP Gene Silencing Inhibits Migration, Invasion, and Bone Metastasis of MDA-MB-231BO Human Breast Cancer Cells
Wang, J., Wang, L., Xia, B., Yang, C., Lai, H., & Chen, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062936 · Cited by 30
Phoyunnanin E inhibits migration of non-small cell lung cancer cells via suppression of epithelial-to-mesenchymal transition and integrin αv and integrin β3
Petpiroon, N., Sritularak, B., & Pithi Chanvorachote, B. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-2059-7 · Cited by 30
Flipping the Switch: Integrin Switching Provides Metastatic Competence
Madamanchi, A., Zijlstra, A., & Zutter, M. M. (2014) · Science Signaling · doi:10.1126/scisignal.2005236 · Cited by 29
NDPKA is not just a metastasis suppressor – be aware of its metastasis-promoting role in neuroblastoma
Tan, C.-Y., & Chang, C. L. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.105 · Cited by 29
Hypoxic activation of PFKFB4 in breast tumor microenvironment shapes metabolic and cellular plasticity to accentuate metastatic competence
Dai, T., Rosario, S. R., Katsuta, E., Dessai, A. S., Paterson, E. J., Novickis, A. T., Gomez, E. C., Zhu, B., Liu, S., Wang, H., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111756 · Cited by 29
Cohesin Is Required for Activation of MYC by Estradiol
McEwan, M. V., Eccles, M. R., & Horsfield, J. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049160 · Cited by 30
Oncogenic features of neuromedin U in breast cancer are associated with NMUR2 expression involving crosstalk with members of the WNT signaling pathway
Garczyk, S., Klotz, N., Szczepanski, S., Denecke, B., Antonopoulos, W., von Stillfried, S. F., Knüchel, R., Rose, M., & Dahl, E. (2017) · Oncotarget · doi:10.18632/oncotarget.16121 · Cited by 29
T-DM1-resistant cells gain high invasive activity via EGFR and integrin cooperated pathways
Endo, Y., Shen, Y., Youssef, L. A., Mohan, N., & Wu, W. J. (2018) · mAbs · doi:10.1080/19420862.2018.1503904 · Cited by 29
ITIH5 induces a shift in TGF‐β superfamily signaling involving Endoglin and reduces risk for breast cancer metastasis and tumor death
Rose, M., Meurer, S. K., Kloten, V., Weiskirchen, R., Denecke, B., Antonopoulos, W., Deckert, M., Knüchel, R., & Dahl, E. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22742 · Cited by 28
Increased metastasis with loss of E2F2 in Myc-driven tumors
Yuwanita, I., Barnes, D., Monterey, M. D., O’Reilly, S., & Andrechek, E. R. (2015) · Oncotarget · doi:10.18632/oncotarget.5690 · Cited by 27
Vasohibin-1 suppresses colon cancer
Liu, S., Han, B., Zhang, Q., Dou, J., Wang, F., Lin, W., Sun, Y., & Peng, G. (2015) · Oncotarget · doi:10.18632/oncotarget.3493 · Cited by 27
Integrin β4 as a Potential Diagnostic and Therapeutic Tumor Marker
Yang, H., Xu, Z., Peng, Y., Wang, J., & Xiang, Y. (2021) · Biomolecules · doi:10.3390/biom11081197 · Cited by 28

Authors: Liu, H., Radisky, D. C., Yang, D., Xu, R., Radisky, E. S., Bissell, M. J., & Bishop, J. M.
Affiliations: University of California, San Francisco (US)
Mayo Clinic in Florida (US)
Lawrence Berkeley National Laboratory (US)
Corresponding author: Radisky, Derek C.
ORCID: Radisky, Derek C.
Yang, Dun
Xu, Ren
Radisky, Evette S.
Bissell, Mina J.
Venue: Nature Cell Biology
Publisher: Springer Science and Business Media LLC
Published: 2012-05-13
Volume: 14
Issue: 6
Pages: 567-574
ISSN: 1465-7392 (ISSN-L)
1476-4679
DOI: 10.1038/ncb2491
PMC: PMC3366024
OpenAlex: W1480621946
Cited by: 181
References: 51
Citations by year: 2026: 7 · 2025: 5 · 2024: 9 · 2023: 7 · 2022: 7 · 2021: 8 · 2020: 12 · 2019: 6 · 2018: 24 · 2017: 16 · 2016: 12 · 2015: 19 · 2014: 25 · 2013: 18 · 2012: 6
FWCI: 8.73
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature Cell Biology (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (CA122086, U54CA126552, CA-116201, R01CA122086, U54CA143836, R37CA064786, U01CA143233, P50CA091956, P50CA116201)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords: c-Myc, metastasis suppression, integrin αvβ3, CD61, ITGAV, transcriptional repression, cell migration, cell invasion, breast cancer, lung metastasis, liver metastasis, tumor xenografts
MeSH terms: Animals, Extracellular Matrix, Humans, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasms, Transcription, Genetic, Proto-Oncogene Proteins c-myc, Gene Silencing, Protein Subunits, Integrin alpha5, Integrin beta3, Cell Line, Tumor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

MYC suppresses cancer metastasis by direct transcriptional silencing of αv and β3 integrin subunits

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks